Oscar Health (OSCR) Stock Looks Cheap Relative To Its Earnings Path - Yahoo Finance

WorldKenya's Health Ministry confirmed the country's second Ebola case Wednesday, saying a relative of the man who died two days after arriving from Congo had tested positive while in quarantine. The man tested positive while in quarantine after developing symptomsThe Associated Press · Posted: Oct 14, 2026 2:19 PM EDT | Last Updated: October 14Listen to this articleEstimated 2 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Health workers and officials stand outside a Ebola isolation facility at the Nairobi Hospital, Kenya, Oct. 7. A second patient in Kenya has tested positive for the disease. (Andrew Kasuku/The Associated Press)Kenya's Health Ministry confirmed the country's second Ebola case Wednesday, saying a relative of the man who died two days after arriving from Congo had tested positive while in quarantine. The ministry said the 39-year-old man had been identified as a close relative of Kenya's first Ebola case and developed symptoms Tuesday.

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.